arrow
M

Miguel Ruiz-Canela

instituto de investigacion sanitaria de navarra
H指数:70
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Longitudinal association of dietary spermidine with hepatic function indexes and cardiometabolic traits in older adults with metabolic syndrome

更正:饮食中精脒与代谢综合征老年人群肝脏功能指标及 cardiometabolic traits 的纵向关联

2026-10-100
PRE
Nuclear magnetic resonance-derived lipoprotein profile and risk of atrial tachyarrhythmia recurrence after catheter ablation: a case-cohort design within the PREDIMAR trial

基于核磁共振的脂蛋白谱与导管消融术后房性心动过速复发的风险:一项PREDIMAR试验中的病例-现况研究设计

2026-10-090
OAAI
Oxidative balance-related metabolite signature and incident cardiovascular disease and type 2 diabetes within the PREDIMED trial

氧化平衡相关代谢物特征与PREDIMED试验中的心血管疾病和2型糖尿病发病

2026-09-010
PRE
Wine consumption, Mediterranean diet, and cardiovascular risk in two Spanish cohorts
2026-02-012
PREAI
Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetes

循环代谢产物,遗传学和生活方式因素与2型糖尿病的未来风险有关

2026-01-140
OAAI
Adherence to the Mediterranean Diet and frailty criteria in an old population with metabolic syndrome: A cross-sectional analysis

地中海饮食依从性与代谢综合征老年人群的虚弱标准:一项横断面分析

2025-12-010
OAAI
Inflammatory dietary potential and gut microbiota in older adults with overweight or obesity and metabolic syndrome

老年超重或肥胖合并代谢综合征患者中的炎症饮食潜力与肠道菌群

2025-08-070
OA
A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts

多代谢物特征稳健地预测了PREDIMED试验和多个美国队列的长期死亡率。

2025-03-170
PRE
Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies

鞘脂谱作为2型糖尿病风险的生物标志物: 来自MIDUS和PREDIMED研究的证据

2024-12-180
OAAI
Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial

尿酒石酸作为葡萄酒消费和心血管风险的生物标志物: PREDIMED试验

2024-12-180
OAAI